Illumina (ILMN) Sinks as Roche Deal Put on Ice
Tweet
Share
E-mail
Get Alerts ILMN Hot Sheet
Join SI Premium – FREE
Illumina, Inc. (NASDAQ: ILMN) is under pressure early after Roche CEO Franz Humer said a deal is now "off the table" because the company is demanding too much.
Illumina reportedly asked Roche for $75/share and previously asked for $68/share.
This morning, Illumina announced the acquisition of Varinta Health for $450 million.
Shares of Illumina last traded at $48.48, down 11.5 percent.
Illumina reportedly asked Roche for $75/share and previously asked for $68/share.
This morning, Illumina announced the acquisition of Varinta Health for $450 million.
Shares of Illumina last traded at $48.48, down 11.5 percent.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hunterbrook bullish on Modine Manufacturing (MOD)
- D.E. Shaw owns $1B+ stake in Sysco - Reuters
- Citadel has shed over 80% of aggregate risk from Situational Awareness portfolio - CNBC
Create E-mail Alert Related Categories
Rumors, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
